Category: Antibody Technologies
Global Antibody Technologies
-
Biosimilar Monoclonal Antibodies Global Market Report 2024
... Inc.; Coherus BioSciences; Biocon Limited Biosimilar Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report ... Read More
-
Monoclonal Antibodies (MAs) Global Market Report 2024
... Research Institute Covering: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Amgen Inc.; Novartis International AG Monoclonal Antibodies (MAs) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management ... Read More
-
Protein Labeling Global Market Report 2024
... Spectrometry; Protein Micro AssayCovering: Thermo Fisher Scientific Inc.; Merck KGaA; PerkinElmer Inc.; General Electric Company; F. Hoffmann-La Roche AG Protein Labeling Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Conjugated Monoclonal Antibodies Global Market Report 2024
... F. Hoffmann-La Roche AG; Bristol -Myers Squibb; Merck & Co. Inc.; Immunomedics Inc. Conjugated Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information ... Read More
-
Global Antibody Drug Conjugates Market - Forecasts from 2024 to 2029
... of US$38.885 billion by 2029, increasing from US$7.017 billion in 2022. Antibody Drug Conjugates, or ADCs for short, are biological drugs designed as a targeted therapy for treating cancer. Antibody-drug conjugates provide sensitive differentiation between ... Read More
-
Postmenopausal Osteoporosis Treatment Market Forecasts to 2030 – Global Analysis By Treatment Type (Bisphosphonates, Hormone Replacement Therapy (HRT), Selective Estrogen Receptor Modulators (SERMs), Monoclonal Antibodies, Calcium and Vitamin D Supplements, Anabolic Agents and Other Treatment Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography
... Types), By Route of Administrations (Oral, Parenteral, Transdermal and Nasal), By Drug Delivery System (Conventional Formulations and Long-Acting Formulations), Patient Demographics, Distribution Channel and By Geography According to Stratistics MRC, the Global Postmenopausal Osteoporosis Treatment ... Read More
-
Protein Engineering Market - By Product (Instrument, Reagent, Software & Services), Technology (Irrational, Rational), Protein (Insulin, Monoclonal Antibody, Vaccine, Growth Factor, Coagulation Factor, Interferon), End-use - Global Forecast, 2024 - 2032
... size is projected to accrue over 15.9% CAGR between 2024 and 2032, propelled by substantial investments from startups. The influx of innovative ventures is injecting dynamism into the industry, driving advancements in protein-based therapeutics, industrial ... Read More
-
Polyclonal Antibodies Global Market Report 2024
... Companies; Diagnostic Centers; HospitalsCovering: Abcam plc; GenScript Biotech Corporation; Merck KGaA; Thermo Fisher Scientific Inc.; Becton Dickinson and Company Polyclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior ... Read More
-
Exosome Research Market by Product & Service (Kits, Reagents (Antibodies, Isolation Purification), Instruments), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell) - Global Forecast to 2028
... to reach USD 356 million by 2028 from an estimated USD 169 million in 2023, at a CAGR of 16.0% during the forecast period. The growth of this market can be attributed to the increasing ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Tuberculosis Diagnostics Test Market - By Test Type (Radiographic, Diagnostic Laboratory, Molecular Diagnostics, Detection of Latent Infection, Cytokine Detection Assay, Detection of Drug Resistance, Phage Assay), End-use - Global Forecast, 2024 - 2032
... Diagnostics Test Market will witness over 5.5% CAGR between 2024 and 2032, spurred by increased availability and efforts to enhance the affordability of these diagnostics. With tuberculosis remaining a global health concern, there is a ... Read More
-
Global Monoclonal Antibody Therapy Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Monoclonal Antibody Therapy industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Monoclonal Antibody Therapy. The report also introduces players ... Read More
-
Pleurodynia Treatment Market by Diagnosis (Blood Test, Culture Test, X-ray), Treatment (Analgesics, Immunoglobulin), Mode Of Administration, End-User - Global Forecast 2024-2030
... expected to reach USD 145.40 million in 2024, at a CAGR 5.66% to reach USD 203.54 million by 2030. Global Pleurodynia Treatment Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Bioengineered Protein Drugs Market by Drug Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), Disease (Arthritis, Autoimmune Disorders, Blood Disorders), End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 415.13 billion in 2024, at a CAGR 7.76% to reach USD 653.35 billion by 2030. Global Bioengineered Protein Drugs Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Cancer Monoclonal Antibodies Market by Type (Chimeric, Human, Humanized), Application (Blood Cancer, Breast Cancer, Colorectal Cancer), End-user - Global Forecast 2024-2030
... and expected to reach USD 78.60 billion in 2024, at a CAGR 12.89% to reach USD 163.28 billion by 2030. Global Cancer Monoclonal Antibodies Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Radioimmunoassays Market by Type (Coated-Tube RIA, Double-Antibody RIA), Product Type (Analyzers, Reagents & Kits), Application, End-User - Global Forecast 2024-2030
... reach USD 468.61 million in 2024, at a CAGR 4.52% to reach USD 612.00 million by 2030. Global Radioimmunoassays Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Radioimmunoassays Market. It ... Read More
-
Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Global Forecast 2024-2030
... expected to reach USD 4.14 billion in 2024, at a CAGR 5.51% to reach USD 5.80 billion by 2030. Global Immunofluorescence Assay Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Biopharmaceutical Fermentation System Market by Product (Downstream Process Product, Upstream Process Product), Application (Antibiotics, Monoclonal Antibodies, Probiotics), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 16.86 billion in 2024, at a CAGR 7.82% to reach USD 26.52 billion by 2030. Global Biopharmaceutical Fermentation System Market FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Diagnostic Specialty Antibodies Market by Antibody (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Polyclonal Antibodies), Application (Dengue Diagnostics, Hepatitis Diagnosis, HIV Diagnostics), End User - Global Forecast 2024-2030
... USD 23.11 billion in 2023 and expected to reach USD 24.36 billion in 2024, at a CAGR 5.49% to reach USD 33.60 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Bioprocess Technology Market by Product (Consumables & Accessories, Instruments), Application (Antibiotics, Biosimilar, Monoclonal Antibodies), End-User - Global Forecast 2024-2030
... reach USD 23.70 billion in 2024, at a CAGR 12.39% to reach USD 47.95 billion by 2030. Global Bioprocess Technology Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Bioprocess Technology ... Read More
-
Antibody Drug Conjugates Contract Manufacturing Market by Linker (Cleavable, Non-cleavable), Condition (Breast Cancer, Lymphoma, Myeloma), End Use - Global Forecast 2024-2030
... in 2023 and expected to reach USD 13.06 billion in 2024, at a CAGR 11.82% to reach USD 25.99 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody ... Read More
-
Antibody Production Market by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies), Process (Downstream Processing, Filtration, Upstream Processing), End-User - Global Forecast 2024-2030
... expected to reach USD 20.16 billion in 2024, at a CAGR 12.40% to reach USD 40.77 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Antibody Production Market. It ... Read More
-
Combination Antibody Therapy Market by Type (Antibody-Drug Conjugates, Bispecific Antibodies, Chemotherapy-Monoclonal Antibodies), Indication (Cancer, HIV), Route of Administration, Distribution Channel, End-Use - Global Forecast 2024-2030
... 209.37 billion in 2023 and expected to reach USD 231.55 billion in 2024, at a CAGR 9.30% to reach USD 390.18 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Oncology Precision Medicine Market by Type (Cell & Gene Therapy, Inhibitor drugs, Monoclonal Antibodies), Cancer Type (Breast Cancer, Cervical Cancer, Colorectal Cancer), End-use - Global Forecast 2024-2030
... at USD 7.34 billion in 2023 and expected to reach USD 7.67 billion in 2024, at a CAGR 9.10% to reach USD 13.51 billion by 2030. Global Oncology Precision Medicine Market FPNV Positioning Matrix The ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
Research Assistance
